[{"Assets_0_Q1_USD":26445500000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":1459500000.0,"NetIncomeLossConverted_1_Q1_USD":1408800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":197000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":196600000.0,"StockholdersEquity_0_Q1_USD":13829900000.0,"StockholdersEquityConverted_0_Q1_USD":13822000000.0,"EarningsPerShareBasic_1_Q1_USD":7.17,"EarningsPerShareDiluted_1_Q1_USD":7.15,"RevenuesConverted_1_Q1_USD":3489800000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190424"}]